Search Results - "McGuire, John J."

Refine Results
  1. 1

    Design and Synthesis of Classical and Nonclassical 6-Arylthio-2,4-diamino-5-ethylpyrrolo[2,3-d]pyrimidines as Antifolates by Gangjee, Aleem, Zeng, Yibin, Talreja, Tina, McGuire, John J, Kisliuk, Roy L, Queener, Sherry F

    Published in Journal of medicinal chemistry (28-06-2007)
    “…The classical antifolate N-{4-[(2,4-diamino-5-ethyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)sulfanyl]benzoyl}-l-glutamic acid (2) and 15 nonclassical analogues (3−17)…”
    Get full text
    Journal Article
  2. 2

    Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review by Kagota, Satomi, McGuire, John J., Maruyama, Kana

    Published in BioMed research international (01-01-2016)
    “…Proteinase-activated receptor 2 (PAR2) is a cell surface receptor activated by serine proteinases or specific synthetic compounds. Interest in PAR2 as a…”
    Get full text
    Journal Article
  3. 3

    Perivascular Adipose Tissue-Enhanced Vasodilation in Metabolic Syndrome Rats by Apelin and N -Acetyl⁻l-Cysteine-Sensitive Factor(s) by Kagota, Satomi, Maruyama-Fumoto, Kana, Iwata, Saki, Shimari, Miho, Koyanagi, Shiori, Shiokawa, Yayoi, McGuire, John J, Shinozuka, Kazumasa

    “…Perivascular adipose tissue (PVAT) can regulate vascular tone. In mesenteric arteries of SHRSP.Z- /IzmDmcr rats (SHRSP.ZF) with metabolic syndrome, vascular…”
    Get full text
    Journal Article
  4. 4

    Preserved arterial vasodilatation via endothelial protease‐activated receptor‐2 in obese type 2 diabetic mice by Kagota, Satomi, Chia, Elizabeth, McGuire, John J

    Published in British journal of pharmacology (01-09-2011)
    “…BACKGROUND AND PURPOSE In non‐obese diabetic animals, protease‐activated receptor‐2 (PAR2) agonists are more effective vasodilators, which is attributed to…”
    Get full text
    Journal Article
  5. 5

    Characterization of Endothelium-Dependent Relaxation in the Saphenous Artery and Its Caudal Branches in Young and Old Adult Sprague Dawley Rats by Wang, Andrea N., Fraser, Graham M., McGuire, John J.

    Published in Biomolecules (Basel, Switzerland) (25-06-2022)
    “…Ageing is associated with reduced endothelium-derived nitric oxide (NO) production in the femoral artery of Sprague Dawley (SD) rats. In the current study, we…”
    Get full text
    Journal Article
  6. 6

    Modulation of Vasomotor Function by Perivascular Adipose Tissue of Renal Artery Depends on Severity of Arterial Dysfunction to Nitric Oxide and Severity of Metabolic Parameters by Kagota, Satomi, Futokoro, Risa, McGuire, John J., Maruyama-Fumoto, Kana, Shinozuka, Kazumasa

    Published in Biomolecules (Basel, Switzerland) (23-06-2022)
    “…Perivascular adipose tissue (PVAT) enhances vascular relaxation of mesenteric arteries in SHRSP.Z-Leprfa/IzmDmcr rats (SPZF), a metabolic syndrome model. We…”
    Get full text
    Journal Article
  7. 7

    Progression of Time-Dependent Changes to the Mechanisms of Vasodilation by Protease-Activated Receptor 2 in Metabolic Syndrome by Maruyama, Kana, McGuire, John J., Kagota, Satomi

    “…Protease-activated receptor 2 (PAR2) is a G protein-coupled receptor activated by serine proteases released from tissues or by synthetic peptide ligands…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Time-Dependent Differences in the Influence of Perivascular Adipose Tissue on Vasomotor Functions in Metabolic Syndrome by Kagota, Satomi, Iwata, Saki, Maruyama, Kana, McGuire, John J, Shinozuka, Kazumasa

    Published in Metabolic syndrome and related disorders (01-06-2017)
    “…Metabolic syndrome (MetS) facilitates the development of cardiovascular disease due to atherosclerosis, which is accelerated by defects of the vascular…”
    Get more information
    Journal Article
  11. 11

    Attenuated vasodilator effectiveness of protease-activated receptor 2 agonist in heterozygous par2 knockout mice by Hennessey, John C, McGuire, John J

    Published in PloS one (07-02-2013)
    “…Studies of homozygous PAR2 gene knockout mice have described a mix of phenotypic effects in vitro and in vivo. However, there have been few studies of PAR2…”
    Get full text
    Journal Article
  12. 12

    2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist by McGuire, John J, Saifeddine, Mahmoud, Triggle, Chris R, Sun, Kimberly, Hollenberg, Morley D

    “…A peptide corresponding to a proteinase-activated receptor 2 (PAR(2))-activating peptide with an N-terminal furoyl group modification, 2-furoyl-LIGRLO-NH(2),…”
    Get more information
    Journal Article
  13. 13

    Enhanced Nitric Oxide Synthase Activation via Protease-Activated Receptor 2 Is Involved in the Preserved Vasodilation in Aortas from Metabolic Syndrome Rats by Maruyama, Kana, Kagota, Satomi, McGuire, John J, Wakuda, Hirokazu, Yoshikawa, Noriko, Nakamura, Kazuki, Shinozuka, Kazumasa

    Published in Journal of vascular research (01-01-2015)
    “…Endothelium-dependent vasodilation via protease-activated receptor 2 (PAR2) is preserved in mesenteric arteries from SHRSP.Z-Leprfa/IzmDmcr rats (SHRSP.ZF)…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Zucker Diabetic‐Sprague Dawley (ZDSD) rat: Type 2 diabetes translational research model by Wang, Andrea N., Carlos, Joselia, Fraser, Graham M., McGuire, John J.

    Published in Experimental physiology (01-04-2022)
    “…New Findings What is the topic of this review? The Zucker Diabetic‐Sprague Dawley (ZDSD) rat is in the early adoption phase of use by researchers in the fields…”
    Get full text
    Journal Article
  16. 16

    Endothelium dysfunction in hind limb arteries of male Zucker Diabetic-Sprague Dawley rats by Wang, Andrea N., Carlos, Joselia, Singh, Krishna K., Fraser, Graham M., McGuire, John J.

    Published in Biochemical pharmacology (01-12-2022)
    “…[Display omitted] Endothelium dysfunction produces peripheral vascular disease comorbidities in type 2 diabetes, including hypertension, and critical limb…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Angiotensin II Type 1 Receptor Antagonist Azilsartan Restores Vascular Reactivity Through a Perivascular Adipose Tissue-Independent Mechanism in Rats with Metabolic Syndrome by Kagota, Satomi, Maruyama-Fumoto, Kana, Shimari, Miho, McGuire, John J., Shinozuka, Kazumasa

    Published in Cardiovascular drugs and therapy (01-10-2019)
    “…Purpose Perivascular adipose tissues (PVAT) are involved in the regulation of vascular tone. In mesenteric arteries, the compensatory vasodilatory effects of…”
    Get full text
    Journal Article
  19. 19

    A Sodium Glucose Cotransporter 2 Inhibitor Fails to Improve Perivascular Adipose Tissue-Mediated Modulation of Vasodilation and Cardiac Function in Rats With Metabolic Syndrome by Kagota, Satomi, Maruyama-Fumoto, Kana, McGuire, John J, Shinozuka, Kazumasa

    “…Arterial perivascular adipose tissue (PVAT) can elicit vasodilator signals complementary to those elicited by the endothelium in SHRSP.Z- /IzmDmcr (SHRSP.ZF)…”
    Get more information
    Journal Article
  20. 20